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Introduction.The IFAP syndrome is a rare X-linked genetic disorder characterized by the triad of follicular ichthyosis, atrichia, and
photophobia. Case Report. A three-month-old Caucasian, male patient was observed with noncicatricial universal alopecia and
persistent eczema from birth. He had dystrophic nails, spiky follicular hyperkeratosis, and photophobia which became apparent at
the first year of life. Short stature and psychomotor developmental delay were also noticed. Histopathological examination of skin
biopsy on left thigh showed epidermis with irregular acanthosis, lamellar orthokeratotic hyperkeratosis, and hair follicles fulfilled by
parakeratotic hyperkeratosis.The chromosomal study showed a karyotype 46, XY. Total IgEwas 374 IU/mL.Onemissensemutation
c.1360G>C (p.Ala454Pro) in hemizygosity was detected on the MBTPS2 gene thus confirming the diagnosis of IFAP syndrome.
Conclusions. We describe a boy with a typical clinical presentation of IFAP syndrome and severe atopic manifestations. A novel
missensemutation c.1360G>C (p.Ala454Pro) inMBTPS2 gene was observed.The phenotypic expression of disease is quantitatively
related to a reduced function of a key cellular regulatory system affecting cholesterol and endoplasmic reticulum homeostasis. It can
cause epithelial disturbance with failure in differentiation of epidermal structures and abnormal skin permeability barrier. However,
no correlation phenotype/genotype could be established.
1. Introduction
The ichthyosis follicularis, atrichia, and photophobia (IFAP)
syndrome is a rare genodermatosis first described by
MacLeod in 1909 [1]. Up to forty cases were described and
most of these had additional features including atopic eczema
in 36% cases [2].
The X-linked recessive mode of inheritance was the
first reported and the gene mapped to the 5.4Mb region
between DXS989 and DXS8019 on Xp22.11-p22.13. Later an
autosomal pattern has been considered [3]. More recently
the missense mutation of the MBTPS2 gene (membrane-
bound transcription factor protease site 2), which codes for
an intramembrane zinc metalloprotease, was found to be
essential for cholesterol homeostasis and endoplasmic retic-
ulum stress response [2].
All affected males have the IFAP triad of follicular
ichthyosis, atrichia of the scalp, and photophobia of varying
degree from birth. Affected or carrier females may display
some of its clinical features such as asymmetric distribution
of body hair, patchy alopecia, and linear lesions of follicular
ichthyosis that follows the lines of Blaschko [1].
2. Case Report
A three-month-old white male patient was referred to the
dermatology department with universal alopecia. The boy
was born underweight (1570 gr) and preterm at 35 weeks and
5 days by natural birth. Pregnancy was uneventful. He has
nonconsanguineous Caucasian parents and there was no
history of similar illness in the family or familiar history of
atopy.
The dermatological examination showed skin phototype
II with a complete absence of scalp hair, eyebrows, and eye-
lashes. He had a prominent forehead, large ears, generalized
dryness of the skin, and follicular papules and pustules on
an erythematous base scattered on the trunk and upper and
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Figure 1: Clinical appearance and dermatologic findings of the patient. Note the alopecia with an absence of scalp hair, eyebrows, and lashes
(a). Spiky follicular hyperkeratosis on the trunk. Skin was dry and scaly and erythematous follicular papules were observed over posterior
aspect of the neck and groin ((c), (d), and (e)), cheilitis (b), and dystrophic nails (f).
lower limbs. A skin biopsy from left arm showed inflam-
matory neutrophilic infiltrate involving adventitial dermis
and a hair follicle with small follicular abscess. A survey of
infectious agents was negative.
Onemonth later, parents reported severe itching and per-
sistent and exudative eczema of the folds mainly in the poste-
rior aspect of the neck and in the groin was observed; cheilitis
and blepharitis were also noted. He underwent conserva-
tive treatment for atopic dermatitis with moisturizers and
topical steroids.
By 4 months of age, he developed a bilateral inguinal
hernia which required surgical correction.
The dermatological examination at 6 months revealed
dystrophic nails and spiky follicular hyperkeratosis for the
extensor surfaces and scalp symmetrically distributed. The
patient kept widespread severe itching and exudative eczema
mainly in the posterior aspect of the neck and groinwith great
interference in sleep (Figure 1).
Investigation, including complete blood count, liver func-
tion tests, serum lipids, immunoglobulins, T-cell subsets, and
leukocyte function studies, was normal. Amino acid studies
of plasma and urine, thyroid function, zinc, folic acid, ferritin,
and urinalysis were unremarkable. Lymphocyte chromosome
study revealed a 46, XY karyotype. Total IgE was 374 IU/mL.
At this point he was observed by a Medical Genetics con-
sultant where the IFAP syndrome was suspected and a new
skin biopsy froman areawithout atopic lesionswas requested.
A new skin biopsy from left thigh performed at 12 months
showed epidermis with irregular acanthosis and orthoker-
atotic lamellar hyperkeratosis (Figure 2). The hair follicles
revealed absence of hair shaft which were fulfilled by parak-
eratotic hyperkeratosis. The sweat glands were normal.
Photophobia became apparent within first years of life.
He was able to walk without help at around 21 months. He
had global developmental delay and, till the age of 28months,
there was no speech acquisition though understanding sim-
ple commands. Dental development was normal. Sweating
was not found to be impaired.
Slit lamp examination revealed the presence of a slight
punctate epithelial keratopathy. Visual acuity was not deter-
mined. Neurological examination and auditory brainstem
response were normal. The left renal pelvis was more
prominent. Abdominal ultrasound and echocardiogramwere
unremarkable.
At the age of 16 months, sequencing of MBTPS2 gene
revealed a missense mutation c.1360G>C (p.Ala454Pro) in
hemizygosity, thus validating the diagnosis of ichthyosis
follicularis with alopecia and photophobia (IFAP-OMIM
number 308205).
The patient remains in followup at dermatology with
inflammatory skin disease characterized by relapses and
remissions of intensely pruritic lesions with a significant
impact on quality of life of the patient and his family. He is
treated for relapseswith cycles of betamethasone oral solution
0.5mg/mL.
3. Discussion
We describe a boy with a typical clinical presentation of IFAP
syndrome and severe atopic manifestations.
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Figure 2: A skin biopsy from left thigh performed at 12 months showed epidermis with irregular acanthosis and orthokeratotic lamellar
hyperkeratosis (a). The hair follicles demonstrate absence of hair shaft and are fulfilled by parakeratotic hyperkeratosis (b).
Table 1
Clinical features in IFAP syndrome
Ocular Photophobia, corneal scars, punctate keratopathy, corneal erosion and neovascularization, and atopickeratoconjunctivitis
Neurological Global developmental delay, seizures, and mild inner cerebral atrophy
Other
Short stature, dysmorphic features such as frontal bossing, choanal atresia, and large ears. Intestinal anomalies
such as omphalocele, Hirschsprung’s disease, congenital aganglionic megacolon, stenosis of the small intestine,
renal, vertebral, and testicular anomalies, inguinal hernia, cleft hands, and recurrent infections
Dermatologic findings are variable. Congenital alopecia is
a distinct clinical finding, which typically involves the scalp,
eyebrows, and eyelashes. There is also complete body hair
alopecia and, in some cases, thin and sparse hair [1].The skin
of the infant is characterized bywidespread noninflammatory
thorn-like follicular projections and symmetrically hyperk-
eratotic spiny papules with a predilection for the extensor
surfaces and scalp [4]. Histologically, there are keratinous
follicular plugging and parakeratosis. There is a thickened
granular layer at the infundibulum with a normal perifollic-
ular granular layer. Poorly developed hair follicles, tending
to be surrounded by an inflammatory infiltrate, reduced
eccrine sweat glands, and absence of sebaceous glands are
typical findings [5]. Other cutaneous manifestations include
psoriasiformplaques, angular cheilitis, periungual inflamma-
tion, hypohidrosis, and atopic eczema. Dystrophic nails are
reported. Dental development is normal.
Ocular [1, 6–8], neurological [6, 9], and other clinical
manifestations associated with IFAP syndrome [10, 11] are
described in Table 1. Photophobia may exist since birth or
may develop later in childhood [1, 7]. It is postulated that a
defect in Bowman membrane results in superficial corneal
ulceration and progressive corneal scarring [8]. Vision acuity
is generally low [8]. Global developmental delay is a common
feature in most patients.
Generalized ichthyosis and alopecia have been reported
in very few syndromes. In our patient, consideration was
given to three diagnoses: ectodermal dysplasia, keratitis-
ichthyosis-deafness syndrome (KID), and the IFAP syn-
drome.
Ectodermal dysplasia is a group of syndromes affecting
the development or function of the ectodermal structures. It
is characterized by sparse hair, abnormal or missing teeth,
and inability to sweat [12]. Ectodermal dysplasia can also be
seen in IFAP syndrome as additional feature [13].
KID syndrome shares many features with IFAP although
most people with KID syndrome have thick, hard skin on
the palms of the hands and soles of the feet (palmoplantar
keratoderma) and hyperkeratotic plaques with an erythe-
matous base (erythrokeratoderma rather than ichthyosis).
Nevertheless, in patients with KID teeth may be malformed
and ocular changes (keratitis and photophobia) are usually
observed during the second and third decades of life [14].
In addition, congenital sensorineural hearing loss in this
condition is usually important and the mode of inheritance
is autosomal dominant.
Clinical manifestations identified in our patient were
consistent with the IFAP syndrome but with severe atopic
skin lesions less common in other patients [15, 16]. The
diagnosis was made although the variable phenotypes which
share similar clinical features with other genodermatoses and
this case report outline the variability of the clinical spectrum.
The diagnosis is based on the clinical features and the
presence ofmissensemutations exchanging highly conserved
amino acids of membrane-bound transcription factor pro-
tease site 2. This is a membrane-embedded zinc metallo-
protease that activates signaling proteins involved in sterol
control of transcription and endoplasmic reticulum (ER)
stress response [10]. Skin histopathology is nonspecific. One
missense mutation c.1360G>C (p.Ala454Pro) in hemizygos-
ity was detected. This variant observed in MBTPS2 is a
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novel mutation not yet described. If association of IFAP
syndrome and severe atopic dermatitis may be fortuitous, the
phenotypic expression of disease is quantitatively related to a
reduced function of a key cellular regulatory system affecting
cholesterol or ER homeostasis. It can cause epithelial distur-
bance with failure in differentiation of epidermal structures
and abnormal skin permeability barrier. However, no corre-
lation phenotype/genotype could be established.
Given the complex pathophysiology of atopic dermatitis,
the therapeutic goal is essentially a multipronged approach
that aimed to repair and protect the skin barrier, reduce
microbial colonization and immune regulation to greater
therapeutic efficacy, and improve quality of life of these
patients. Routine symptomatic treatment of the generalized
follicular hyperkeratosis is performed with topical keratolyt-
ics and emollients. Oral retinoids have previously been used
with moderate response in cutaneous features in other boys
on oral acitretin at a dosage of 0.3 to 1mg/kg/day. However,
photophobia and alopecia did not improve [17].
Life expectancy in patients with IFAP syndrome can vary
from death in the neonatal period to normal survival. Car-
diopulmonary complications remain themajor cause of death
[14].
IFAP syndrome cannot be detected prenatally by ultra-
sonography. The mutation might also arise in the patient de
novo [2]. If the mutation has been previously detected in the
family, prenatal diagnosis can be offered to female carriers.
The patient’s mother was healthy with no relevant medical
or surgical history. Currently, genetic study of the mother is
ongoing.
4. Conclusion
IFAP syndrome is an X-linked genodermatosis with variable
severity and genetic mutations that were found to imply
MBTPS2 gene as causal. Modifying factors might modulate
the phenotype in this syndrome and a better knowledge of
the MBTPS2 gene may help understand the mechanism of
its enzymatic action. The prognosis is mainly determined by
cutaneous and extracutaneous manifestations so a multidis-
ciplinary approach to these patients is imperative.
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